Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients.

Milou A M StalsMjjh GrootenboersC van GuldenerFhj KapteinSje BrakenQingui ChenG ChuE M van DrielA Iglesias Del SolE de JongeK M KantF PalsMyrthe M A Toorop Suzanne C Cannegieter Frederikus Albertus KlokM V Huismannull null

Published in: Research and practice in thrombosis and haemostasis (2021)

The incidence of thrombotic complications in hospitalized influenza patients was lower than in hospitalized COVID-19 patients. This difference was mainly driven by a high risk of VTE complications in the COVID-19 patients admitted to ICU. Remarkably, influenza patients were more often diagnosed with arterial thrombotic complications.

Keyphrases

end stage renal disease
sars cov
risk factors
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
venous thromboembolism
intensive care unit
patient reported outcomes
patient reported
extracorporeal membrane oxygenation